Biomarkers of Hypercoagulability in COVID-19

Biomarkers of Hypercoagulability in COVID-19

This issue focuses on the pathophysiology of coronavirus disease 2019 (COVID-19) [...]

Bibliographic Details
Main Author:	Hideo Wada
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Journal of Clinical Medicine
Subjects:	n/a
Online Access:	https://www.mdpi.com/2077-0383/12/10/3525

Similar Items

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
by: Hiroki Kitakata, et al.
Published: (2021-07-01)

COVID-19 and Biomarkers: The Contribution of the Journal
by: Mario Plebani
Published: (2023-02-01)

The Burden of Hypercoagulability in COVID-19
by: Madeleine Kim, et al.
Published: (2022-04-01)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
by: Shibeeb S, et al.
Published: (2021-08-01)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
by: Mingshan Jiang, et al.
Published: (2021-01-01)

Hypercoagulability in Severe COVID Infection
by: Mohammed Fauzi Abdul Rani
Published: (2023-03-01)

Coronavirus Disease Pathophysiology: Biomarkers, Potential New Remedies, Comorbidities, Long COVID-19, Post Pandemic Epidemiological Surveillance
by: Jacek Z. Kubiak, et al.
Published: (2023-07-01)

Reply to Ishikura, H. What Does Soluble C-Type Lectin-like Receptor 2 (sCLEC-2) × D-Dimer/Platelet (PLT) (sCLEC-2 × D-Dimer/PLT) Mean for Coagulation/Fibrinolysis Conditions? Comment on “Yamamoto et al. Super Formula for Diagnosing Disseminated Intravascular Coagulation Using Soluble C-Type Lectin-like Receptor 2. <i>Diagnostics</i> 2023, <i>13</i>, 2299”
by: Hideo Wada, et al.
Published: (2023-12-01)

Recent Progress in Research on COVID-19 Pathophysiology: Biomarkers, Repurposed Drugs, Viral Invasiveness, SARS-CoV-2 Genetic Diversity, the Crystal Structure of Viral Proteins, and the Molecular and Cellular Outcomes of COVID-19
by: Jacek Z. Kubiak, et al.
Published: (2022-11-01)

The pathogenesis of COVID-19: Hypercoagulation and D-dimer in thrombotic complications
by: Leonid DUBEY, et al.
Published: (2023-03-01)

Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID‐19
by: George Goshua, et al.
Published: (2021-01-01)

Thrombotic Mechanism Involving Platelet Activation, Hypercoagulability and Hypofibrinolysis in Coronavirus Disease 2019
by: Hideo Wada, et al.
Published: (2023-04-01)

The Impact of COVID-19 and Non-COVID-19 Vaccinations in Special Populations
by: Kay Choong See
Published: (2024-01-01)

COVID-19 in 2021
by: Kenneth Lundstrom, et al.
Published: (2021-10-01)

Hypercoagulability and thrombosis
by: Maria Domenica Cappellini, et al.
Published: (2013-03-01)

Looking at the Impact of COVID-19 on Religious Practice and the Impact of Religious Practice on COVID-19
by: Joel Zimbelman, et al.
Published: (2023-07-01)

COVID-19 and Molecular Genetics
by: Giuseppe Novelli, et al.
Published: (2022-04-01)

Analgesic Drugs and COVID-19
by: Giustino Varrassi
Published: (2021-02-01)

COVID-19 and Social Sciences
by: Carlos Miguel Ferreira, et al.
Published: (2020-12-01)

Oral Mycobiome and COVID-19
by: Francesco D’Ambrosio
Published: (2023-04-01)

COVID-19 Prevention and Treatment
by: Silvia De Francia, et al.
Published: (2023-03-01)

Dissecting Physiopathology of COVID-19
by: Jacek Z. Kubiak, et al.
Published: (2022-08-01)

Cellular Immunology and COVID-19
by: Isabella Quinti
Published: (2021-12-01)

COVID-19 and Kidney Transplantation
by: Maurizio Salvadori, et al.
Published: (2021-07-01)

Boredom in the COVID-19 Pandemic
by: James Danckert
Published: (2022-11-01)

On the Waves of the COVID-19 Pandemic
by: Michele Roccella, et al.
Published: (2023-02-01)

COVID-19 and Post-Acute COVID-19 Syndrome: From Pathophysiology to Novel Translational Applications
by: Pasquale Ambrosino, et al.
Published: (2021-12-01)

Risk Factors and Mortality in Elderly ARDS COVID-19 Compared to Patients without COVID-19
by: Davide Chiumello, et al.
Published: (2022-09-01)

COVID-19 and the Eye: Impact of COVID-19 Pandemic on Clinical, Surgical and Research Activities in Ophthalmology
by: Giuseppe Giannaccare, et al.
Published: (2022-05-01)

Hypercoagulability in critically ill patients with COVID 19, an observational prospective study
by: Laure Calvet, et al.
Published: (2022-01-01)

Hypercoagulability in critically ill patients with COVID 19, an observational prospective study.
by: Laure Calvet, et al.
Published: (2022-01-01)

Letter to the Editor re: Late diagnosis of COVID-19 and hypercoagulable state
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-06-01)

Hypercoagulability and Anticoagulation in Patients With COVID-19 Requiring Renal Replacement Therapy
by: Lara N. Roberts, et al.
Published: (2020-09-01)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
by: Sinda Zarrouk, et al.
Published: (2021-09-01)

Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications
by: MA Haimei
Published: (2020-07-01)

Relationship Among Clinically Obtained Biomarkers of Inflammation, Hypercoagulability, and Macrophage Activation, and Delirium in Critically Ill Patients With COVID-19
by: Sikandar H. Khan, DO, MS, et al.
Published: (2023-01-01)

Biomarkers in Pain
by: Anders O. Larsson, et al.
Published: (2023-09-01)

Biomarkers of Sepsis
by: Luisa Agnello, et al.
Published: (2023-01-01)

Remarks on Myocarditis Associated with COVID-19 Infection and Myocarditis Following mRNA COVID-19 Vaccination
by: Andrea Frustaci
Published: (2022-11-01)

Advances and Challenges in COVID-19 and Pneumonia
by: Zichen Ji, et al.
Published: (2024-02-01)